Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

White wax and policosanol from white wax effectively reduced hair loss and promoted hair growth in mice better than a known hair growth drug.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Many patients on new leukemia drugs had mild to moderate skin reactions.

New acne treatments show promise as alternatives to traditional therapies.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

New psoriasis treatments are effective but come with side effects and risks.

Nanoemulsions with minoxidil and clove oil effectively target hair follicles for better alopecia treatment.

Substance from human umbilical cord blood cells promotes hair growth.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Using tiny fat particles to deliver arginine to hair follicles could be a new way to treat hair loss.